adalimumab-bwwd

CHEBI:CHEBI_752368

Drug Classification

Important Medical Information

⚕️ This information is sourced from ChEBI (Chemical Entities of Biological Interest) database and is intended for educational purposes only.

  • Always consult with a healthcare professional before starting, stopping, or modifying any medication.
  • Side effects may vary and this list may not be comprehensive.
  • Drug interactions may occur with other medications.

Additional Identifiers

🔍 Click on any linked disease name to learn more about the conditions this medication is used to treat, or explore related drug classifications for more information about similar medications.

Additional Attributes

rxcui
2640432
pharm_class
Monoclonal [CS]
product_type
HUMAN PRESCRIPTION DRUG
listing_expiration_date
20241231
dosage_form
SOLUTION
route
SUBCUTANEOUS
package_marketing_start_date
20230927
marketing_category
BLA
marketing_start_date
20230701
active_ingredient_strength
40 mg/.8mL
active_ingredient_name
ADALIMUMAB
unii
FYS6T7F842
nui
M0001357
pharm_class_epc
Tumor Necrosis Factor Blocker [EPC]
pharm_class_moa
Tumor Necrosis Factor Receptor Blocking Activity [MoA]
pharm_class_cs
Antibodies, Monoclonal [CS]
labeler_name
A-S Medication Solutions
manufacturer_name
A-S Medication Solutions
generic_name
adalimumab-bwwd
brand_name
HADLIMA
brand_name_base
HADLIMA
product_ndc
78206-185
application_number
BLA761059
spl_id
c43bbba6-5049-486a-9d8a-92e72d2937f9
package_ndc
78206-185-01
package_description
1 CARTON in 1 CARTON (78206-185-01) / 1 VIAL in 1 CARTON (78206-185-99) / .8 mL in 1 VIAL
spl_set_id
ccd54ad1-2fcf-4b1f-96a3-f3b2f3323383
22-rdf-syntax-ns#type
http://www.w3.org/2002/07/owl#Class